More recently, a report used the CRISPR-Cas system to engineer Brain-Derived Neurotrophic Factor (BDNF)-overexpressing MSCs that were applied to effectively treat Rett syndrome in an experimental mouse model [130]. Here, BDNF is linked to Rett syndrome.